Scatena, Cristian, Roberto Ravasio, Paola Raimondo, and Mario Giuliano. “A Budget Impact Analysis of the VENTANA PD-L1 SP142 Immunohistochemistry Assay Versus the Dako PD-L1 IHC 22C3 Assay in Patients With Advanced or Metastatic Triple-Negative Breast Cancer Treated With Atezolizumab in Combination With Nab-Paclitaxel”. Farmeconomia. Health economics and therapeutic pathways 22, no. 1 (July 26, 2021). Accessed July 23, 2025. https://provafe.seedstm.com/index.php/FE/article/view/1502.